Curaleaf Holdings (CURLF) Operating Income (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Operating Income of $753000.0 for Q1 2026, down 91.96% year-over-year from $9.4 million in Q1 2025, and down 92.69% quarter-over-quarter from $10.3 million in Q4 2025.
Curaleaf Holdings (CURLF) Operating Income (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Operating Income history runs 8 years deep, the most recent figure standing at $753000.0 for Q1 2026.
- In Q1 2026, Operating Income fell 91.96% year-over-year to $753000.0; the TTM figure through Mar 2026 stood at $18.4 million (down 14.15% YoY), while the FY2025 annual figure was $25.4 million, up 2.86% from the prior year.
- Operating Income for Q1 2026 stood at $753000.0, down from $10.3 million in the prior quarter.
- The five-year high for Operating Income was $43.7 million in Q1 2022, with the low at -$81.5 million in Q4 2022.
- The 5-year median for Operating Income is $7.5 million (2024), against an average of $5.8 million.
- The sharpest annual moves came in 2024 and 2025: Operating Income sank 34001.34% in 2024, then soared 73636.42% in 2025.
- Curaleaf Holdings' Operating Income stood at -$81.5 million in 2022, then jumped by 100.02% to $13967.0 in 2023, then tumbled by 34001.34% to -$4.7 million in 2024, then surged by 317.7% to $10.3 million in 2025, then slumped by 92.69% to $753000.0 in 2026.
- Business Quant data shows CURLF's Operating Income at $753000.0 in Q1 2026, $10.3 million in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | 4.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.22 Mn |
| Mar 31, 2026 | 753,000.00 |
| Dec 31, 2025 | 10.31 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 9.37 Mn |
| Dec 31, 2024 | -4.74 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 7.55 Mn |
| Mar 31, 2024 | 12,702.00 |
| Dec 31, 2023 | 13,967.00 |
| Sep 30, 2023 | 15.21 Mn |
| Jun 30, 2023 | -4.28 Mn |
| Mar 31, 2023 | 17.98 Mn |
| Dec 31, 2022 | -81.53 Mn |
| Sep 30, 2022 | 32.51 Mn |
| Jun 30, 2022 | 35.10 Mn |
| Mar 31, 2022 | 43.73 Mn |
| Dec 31, 2021 | 10.49 Mn |
| Sep 30, 2021 | 42.38 Mn |